Beta blockers to reduce the risk of heart attack or heart failure after surgery

    There's a lot of talk recently about using beta blockers to reduce the risk of heart attack or heart failure after surgery.

    Researchers say this could save 25,000 lives a year.

    The beta blocker, atenolol (Tenormin), is being given to surgical patients who have coronary artery disease.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote